This website uses cookies
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
Consent Selection
Details
  • Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
    • We do not use cookies of this type.

  • Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
    • We do not use cookies of this type.

  • Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
    • We do not use cookies of this type.

  • Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
    • __emg_sidPending
      Maximum Storage Duration: 1 dayType: HTTP Cookie
      __emg_vidPending
      Maximum Storage Duration: 1 yearType: HTTP Cookie
      nl-read-countPending
      Maximum Storage Duration: PersistentType: HTML Local Storage
Cookie declaration last updated on 8/12/26 by Cookiebot
[#IABV2_TITLE#]
[#IABV2_BODY_INTRO#]
[#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#]
[#IABV2_BODY_PREFERENCE_INTRO#]
[#IABV2_BODY_PURPOSES_INTRO#]
[#IABV2_BODY_PURPOSES#]
[#IABV2_BODY_FEATURES_INTRO#]
[#IABV2_BODY_FEATURES#]
[#IABV2_BODY_PARTNERS_INTRO#]
[#IABV2_BODY_PARTNERS#]
About
Cookies are small text files that can be used by websites to make a user's experience more efficient.

The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission.

This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.

You can at any time change or withdraw your consent from the Cookie Declaration on our website.

Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy.

Please state your consent ID and date when you contact us regarding your consent.
NewsLayer.com
NewsLayer PulseLIVEBTC$79,406+2.94%ETH$2,512+2.98%SOL$96.04+0.73%XRP$1.51+0.93%DOGE$0.0918-0.62%ADA$0.2235-0.49%Total Cap$2.81T+2.52%Layer Index70 Greed

Zerostack's $4.71 stock was 74.1% below its crypto value per share

Zerostack (NASDAQ: ZSTK) reported that, using coinmarketcap.com prices as of August 23, 2026, 10pm EST, its cryptocurrency holdings in MemeCore and 0G had an aggregate indicative market value of approximately $1.06 billion. This equates…

Stock Titan

Publisher

Aug 24, 2026 at 1:20 PM UTC · 16 분 소요

Zerostack's $4.71 stock was 74.1% below its crypto value per share
Image via Stock Titan
번역 중…

Zerostack Corp. Reports Cryptocurrency Holdings with Aggregate Market Value of Approximately $1.06 Billion, Representing Approximately $18.19 Per Partially Diluted Share

Zerostack (NASDAQ: ZSTK) reported that, using coinmarketcap.com prices as of August 23, 2026, 10pm EST, its cryptocurrency holdings in MemeCore and 0G had an aggregate indicative market value of approximately $1.06 billion. This equates to about $18.19 per partially diluted share, based on roughly 58.5 million common shares and pre-funded warrants.

On a fully diluted basis of approximately 61.4 million shares and equivalents, the company calculated around $17.33 of cryptocurrency market value per share. Using a reference common stock price of $4.71 on August 21, 2026, Zerostack calculated discounts of about 74.1% (partially diluted) and 72.8% (fully diluted) versus these crypto value measures.

Management believes the value of its pharmaceutical business and other non-crypto assets is sufficient to offset liabilities, and views cryptocurrency market value per share as a supplemental non-GAAP metric, subject to significant volatility, liquidity limits, tax and transaction costs, and other risks.

Loading...

Loading translation...

Article Intelligence

Topics

Sponsored

Ad
House — Advertise on NewsLayer
NewsLayerLearn more

NewsLayer Premium

Unlock deeper intelligence.

Ad-free reading, exclusive research, and real-time onchain insights.

Go Premium